Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 2 Glomerular pathology in mice and humans with diabetic nephropathy Figure 2 | Glomerular pathology in mice and humans with diabetic nephropathy.

Published byJeffry Atkins Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 2 Glomerular pathology in mice and humans with diabetic nephropathy Figure 2 | Glomerular pathology in mice and humans with diabetic nephropathy."— Presentation transcript:

1 Figure 2 Glomerular pathology in mice and humans with diabetic nephropathy
Figure 2 | Glomerular pathology in mice and humans with diabetic nephropathy. a | Normal mouse glomerulus. b | Representative glomerulus from a 24-week old Akita mouse on the 129 SvEv strain, which is fairly permissive to kidney injury in diabetes. Pathological changes are limited to modest expansion of the mesangial matrix (arrows). c | Glomerulus from a patient with diabetic nephropathy showing typical nodular sclerosis and a Kimmelstiel–Wilson nodule (arrow). Images are photomicrographs of kidney sections with Periodic acid–Schiff staining, magnification ×400. Azushima, K. et al. (2017) Modelling diabetic nephropathy in mice Nat. Rev. Nephrol. doi: /nrneph

Download ppt "Figure 2 Glomerular pathology in mice and humans with diabetic nephropathy Figure 2 | Glomerular pathology in mice and humans with diabetic nephropathy."

Similar presentations

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.
Figure 6 Effects of adiponectin on podocyte function

Figure 6 Effects of adiponectin on podocyte function
Figure 2 Pathology of scleroderma renal crisis

Figure 2 Pathology of scleroderma renal crisis
Figure 6 Differences in glycaemic control with the study drug

Figure 6 Differences in glycaemic control with the study drug
Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.
Figure 4 Expression of coagulation protease receptors in renal cells

Figure 4 Expression of coagulation protease receptors in renal cells
Volume 81, Issue 11, Pages (June 2012)

Volume 81, Issue 11, Pages (June 2012)
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 2 Physiological changes in the renal system in pregnancy

Figure 2 Physiological changes in the renal system in pregnancy
Volume 85, Issue 3, Pages (March 2014)

Volume 85, Issue 3, Pages (March 2014)
Figure 1 Pathological features of lupus nephritis subtypes

Figure 1 Pathological features of lupus nephritis subtypes
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Pathologic features of obesity-related glomerulopathy (ORG)

Figure 1 Pathologic features of obesity-related glomerulopathy (ORG)
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.

Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.
Figure 7 The efficacy of phosphate-binder therapy

Figure 7 The efficacy of phosphate-binder therapy
Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)

Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)

Similar presentations

Ads by Google